BiotechTube
BiosanaPharma

BiosanaPharma

Amsterdam, Netherlands· Est.
biosanapharma.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $25M

Overview

BiosanaPharma is a technology provider specializing in continuous manufacturing solutions for biologics production. The company's core offering is its '3C' automation platform, which enables fully integrated, GMP-ready continuous downstream processing (DSP) and is scalable from 50L to 2000L. Having transitioned from R&D to commercialization, BiosanaPharma licenses its platform and provides comprehensive implementation services, including process design, equipment procurement, and personnel training. Its business model targets biopharma companies and CDMOs seeking to enhance manufacturing efficiency and reduce the cost of goods for complex biologics.

BiosimilarsDrug Delivery

Technology Platform

Proprietary '3C' biodigital automation platform for continuous downstream processing (DSP) of biologics. It is a flexible, unit operation-independent system with integrated automatic sampling and on/at-line analytics, scalable from 50L to 2000L. The platform supports full process implementation and is under continuous development with AI/ML integration.

Funding History

1
Total raised:$25M
Series A$25M

Opportunities

The global push for affordable biologics and biosimilars, coupled with regulatory encouragement for advanced manufacturing, creates a large market for continuous processing solutions.
BiosanaPharma's flexible, automation-driven platform is well-suited to help CDMOs and pharma companies increase output and reduce costs, positioning it to capture significant value as the industry modernizes.

Risk Factors

Key risks include slow adoption of continuous manufacturing by a conservative industry, intense competition from large, established equipment vendors, and execution challenges in scaling complex implementation projects across multiple global client sites simultaneously.

Competitive Landscape

BiosanaPharma competes in the advanced biomanufacturing technology space against large integrated equipment vendors (e.g., Sartorius, Thermo Fisher, Cytiva) who offer their own continuous processing solutions. Its differentiation lies in its flexible, vendor-agnostic automation platform and comprehensive 'Field Lab' implementation service, targeting clients who want to avoid single-vendor lock-in.

More companies in Biologics / Biosimilars →More companies in Netherlands →